JAK2 and acquired polycythemia vera: In humans, analysis of the TET2 gene in bone marrow cells from 320 patients with myeloid cancers identified TET2 defects in 13 patients with polycythemia vera, all of whom also displayed the JAK2 V617F mutation [65].